New implant connection helps enhance surgical efficiency for immediate implant procedures
BioHorizons Camlog has announced the release of Tapered Pro Conical, the company’s first dental implant with a deep conical connection in the UK and Ireland. This new implant reflects BioHorizons’ dedication to developing innovative products that enhance clinical performance and workflow efficiency, part of a broader strategy by parent company Henry Schein, Inc., to invest in technological advances for the benefit of the practice and patient.
Tapered Pro Conical leverages the successful macro design of Tapered Pro with the proven and patented CONELOG® connection to provide clinicians with a predictable solution for immediate treatment, from single tooth to full arch. It is designed for surgical efficiency with a best-in-class conical connection.
“Backed by more than 30 years of research, Tapered Pro Conical’s Laser-Lok microchannels create a connective tissue attachment and retain crestal bone, thus allowing better control of clinical and esthetic outcomes,” said Steve Boggan, Co-CEO of the Global Oral Reconstruction Group of Henry Schein. “We recognise the importance of immediate and predictable solutions for implant therapy, and are pleased to deliver enhanced functionality with this new implant.”
The new implant’s tapered body and aesthetic thread design provide primary stability, while its self-tapping helical cutting flutes are designed to help control implant placement. A new surgical kit – combining freehand and keyless guided surgical approaches – further enhances surgical efficiency. Clinicians also benefit from restorative simplicity with just two prosthetic platforms.
The CONELOG® Implant System was introduced in 2011 by Camlog to enlarge its offerings with conical implant to abutment connections. CONELOG® Implants have a 7.5-degree self-locking inner taper and three internal grooves.
Learn more about the new Tapered Pro Conical and guided surgery options available here.
About BioHorizons Camlog
BioHorizons Camlog is a leading supplier of premium dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions. It is committed to developing evidence-based and scientifically proven products, as well as continuing education adhering to highest standards.
Headquartered in the U.S. and Europe, BioHorizons Camlog’s geographic positions allow it to efficiently serve direct subsidiaries in the Americas and Western Europe, as well as its entire distribution network in more than 90 countries around the world.
The company is part of Henry Schein Inc., a solutions company for healthcare professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, Henry Schein’s network of trusted advisors provides over 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.
For more information, visit www.biohorizonscamlog.com and www.henryschein.com.
